CONTRA FUSION PHARMACE EQUITY is a security (CUSIP 361CVR012) tracked across SEC portfolio filings. 2 institutional managers reported positions on Form 13F as of 2026-06-30; 4 registered fund positions totaling $30K via N-PORT as of 2026-03-31.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Skaana Management L.P. | BROOKLYN, NY | — | 50,000 |
| GAMMA Investing LLC | FOSTER CITY, CA | — | 14 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| abrdn Healthcare Investors | abrdn Healthcare Investors | $10K | 0.09% |
| abrdn Healthcare Opportunities Fund | abrdn Healthcare Opportunities Fund | $10K | 0.14% |
| abrdn World Healthcare Fund | abrdn World Healthcare Fund | $5K | 0.11% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $4K | 0.08% |